MedDataX Logo

Comparison of 20-core Versus 12-core Prostate Biopsy Diagnostic Performance in the Detection of Prostate Cancer

NCT ID: NCT00992615

Last Updated: 2012-08-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The optimal number of prostate cores extracted during a prostate biopsy performed because of a suspected prostate cancer is still debated. The present consensus is to sample 12 cores. However, recent data published in the literature brought arguments in favour of a higher number, probably 20. This would have the advantages of decreasing the false negatives and the re-biopsy rate.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Prostate Cancer

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Arm 20 cores

Group Type EXPERIMENTAL

prostate biopsy

Intervention Type PROCEDURE

prostate cores - 12 or 20

arm 12 cores

Group Type ACTIVE_COMPARATOR

prostate biopsy

Intervention Type PROCEDURE

prostate cores - 12 or 20

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

prostate biopsy

prostate cores - 12 or 20

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients older than 18
* Patients with a PSA value between 3 et 20 ng/ml
* Obtained informed consent
* Patients able to comply with the study protocol
* Patients covered by a social insurance

Exclusion Criteria

* None
Minimum Eligible Age

18 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Poitiers University Hospital

OTHER

Sponsor Role lead

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

service d'Urologie - CHU de Poitiers - 2 rue de la Milétrie

Poitiers, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Irani J, Blanchet P, Salomon L, Coloby P, Hubert J, Malavaud B, Mottet N. Is an extended 20-core prostate biopsy protocol more efficient than the standard 12-core? A randomized multicenter trial. J Urol. 2013 Jul;190(1):77-83. doi: 10.1016/j.juro.2012.12.109. Epub 2013 Jan 9.

Reference Type DERIVED
PMID: 23313205 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

BP20-12

Identifier Type: -

Identifier Source: org_study_id